A detailed history of Vanguard Group Inc transactions in Nexgel, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 49,975 shares of NXGL stock, worth $167,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,975
Previous 28,626 74.58%
Holding current value
$167,416
Previous $61,000 109.84%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.04 - $3.19 $43,551 - $68,103
21,349 Added 74.58%
49,975 $128,000
Q2 2024

Aug 13, 2024

BUY
$2.06 - $2.38 $6,386 - $7,378
3,100 Added 12.14%
28,626 $61,000
Q4 2023

Feb 14, 2024

BUY
$1.5 - $2.35 $1,473 - $2,307
982 Added 4.0%
25,526 $54,000
Q3 2023

Nov 14, 2023

BUY
$1.75 - $2.52 $42,952 - $61,850
24,544 New
24,544 $52,000

Others Institutions Holding NXGL

About NEXGEL, INC.


  • Ticker NXGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 5,572,230
  • Market Cap $18.7M
  • Description
  • NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...
More about NXGL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.